Page last updated: 2024-09-05

aezs 124 and Colonic Neoplasms

aezs 124 has been researched along with Colonic Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aigner, E; Buchholz, S; Datz, C; Halmos, G; Hohla, F; Koster, F; Krishan, A; Papadia, A; Rick, FG; Schally, AV; Seitz, S; Szalontay, L	1

Other Studies

1 other study(ies) available for aezs 124 and Colonic Neoplasms

Article	Year
Targeted cytotoxic somatostatin analog AN-162 inhibits growth of human colon carcinomas and increases sensitivity of doxorubicin resistant murine leukemia cells. Cancer letters, 2010, Aug-01, Volume: 294, Issue:1 Topics: 2-Hydroxyphenethylamine; Aniline Compounds; Animals; Cell Cycle; Cell Division; Cell Survival; Colonic Neoplasms; Colorectal Neoplasms; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; Leukemia, Experimental; Male; Mice; Mice, Nude; Receptors, Somatostatin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Somatostatin	2010

Article

Year

Targeted cytotoxic somatostatin analog AN-162 inhibits growth of human colon carcinomas and increases sensitivity of doxorubicin resistant murine leukemia cells.

Cancer letters, 2010, Aug-01, Volume: 294, Issue:1

Topics: 2-Hydroxyphenethylamine; Aniline Compounds; Animals; Cell Cycle; Cell Division; Cell Survival; Colonic Neoplasms; Colorectal Neoplasms; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; Leukemia, Experimental; Male; Mice; Mice, Nude; Receptors, Somatostatin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Somatostatin

2010